Search the Community
Showing results for tags 'iloprost'.
Found 3 results
Acute and chronic effects of two different intravenous iloprost (ILO) regimens in systemic sclerosis: a pragmatic non–randomized trial. ILO had an acute effect as assessed by power Doppler US and by contrast, an ILO chronic effect was not detectable before the following infusion in both treatment groups. PubMed, Rheumatology (Oxford), 05/03/2018. (Also see Inhaled Prostacyclin) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
The safety of iloprost (ILO) in systemic sclerosis in a real–life experience. Our data suggest that calcium channel blockers should be transitorily stopped while using ILO and that a pre–treatment approach might reduce or control adverse events. PubMed, Clin Rheumatol, 02/22/2018. (Also see Inhaled Prostacyclin (Iloprost, Ventavist)) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.